Ginger Johnson

Ginger S. Johnson, PhD, is the President of Commercial BioConsulting at Lumanity, a role in which she leads core assessment and strategic consulting engagements with a special focus on Central Nervous System (CNS) related categories.14

Professional Background

Dr. Johnson has an extensive and diverse background in the life sciences industry:

• Current Role: President of Commercial BioConsulting and Co-Lead for Central Nervous System at Lumanity2
• Previous Positions:
  • Director of Life Science Research at Chase Capital Partners (now CCMP Capital)
  • Associate Director of the Center for Biotechnology at Northwestern University
  • Researcher at the National Institute of Mental Health and a start-up biotechnology company

Education

• Bachelor of Science in Molecular Biology from the University of Tennessee
• Doctorate in Molecular Biology from George Washington University in Washington, DC
• Completed graduate studies at the Kellogg Graduate School of Management at Northwestern University1

Expertise and Contributions

Dr. Johnson's expertise spans various areas of the biotechnology and pharmaceutical industries:

• Research Focus: Specialized in Alzheimer's disease and other neurodegenerative diseases
• Publications: Author of multiple peer-reviewed articles
• Patents: Holds three issued patents
• Investment Experience: Focused on high-growth opportunities in emerging areas within pharmaceutical, biotechnology, and medical device industries
• Academic Contribution: Helped develop an innovative graduate program combining science and business of biotechnology at Northwestern University1

Dr. Johnson is recognized as a leader in her field, having been featured as a panelist in discussions about women leaders in biotechnology.5 Her LinkedIn profile, under the username ginger-johnson-845437, lists her current position at Lumanity and indicates she has over 500 connections in her professional network.3